Rho Works to Promote Clinical Trial Patient Diversity

While anecdotal evidence and data from the U.S. Food and Drug Administration (FDA) suggest progress has been incremental at best, former clinical research associate (CRA) Sharon Duffy remains “optimistic” that […]